1. Petrosky, E., Bocchini, J. A., & Hariri, S. (2015). Use of 9-valent Human Papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report,
64(11), 300–304.
2. Bauer, H. M., Wright, G., & Chow, J. (2012). Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007–2010. American Journal of Public Health,
102(5), 833–883.
3. Centers for Disease Control and Prevention. (2018). HPV and cancer. Retrieved August 29, from
https://www.cdc.gov/cancer/hpv/statistics/index.htm/
.
4. Kahn, J. A., Widdice, L. E., Ding, L., Huang, B., Brown, D. R., Franco, E. L., et al. (2016). Substantial decline in vaccine-type Human Papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a community. Clinical Infectious Disease,
63(10), 1281–1287.
5. US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. (2019). Immunization and infectious diseases: Objectives. Retrieved April 1, from
https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives
.